Publications by authors named "Andrew Spencer"

100Publications

Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.

Lancet Haematol 2020 Jun 30;7(6):e456-e468. Epub 2020 Apr 30.

Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(20)30099-5DOI Listing
June 2020

Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma.

Leukemia 2020 Apr 21. Epub 2020 Apr 21.

Malignant Haematology & Stem Cell Transplantation Service, The Alfred Hospital, Monash University, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-020-0834-9DOI Listing
April 2020

Brick plots: an intuitive platform for visualizing multiparametric immunophenotyped cell clusters.

BMC Bioinformatics 2020 Apr 15;21(1):145. Epub 2020 Apr 15.

Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12859-020-3469-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158154PMC
April 2020

Patient-reported outcome measures in multiple myeloma: Real-time reporting to improve care (My-PROMPT) - a pilot randomized controlled trial.

Am J Hematol 2020 07 20;95(7):E178-E181. Epub 2020 Apr 20.

School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25815DOI Listing
July 2020

Targeting MCL-1 in hematologic malignancies: Rationale and progress.

Blood Rev 2020 Feb 21:100672. Epub 2020 Feb 21.

Gehr Family Center for Leukemia, City of Hope Medical Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2020.100672DOI Listing
February 2020

Bioprinting of a Cell-Laden Conductive Hydrogel Composite.

ACS Appl Mater Interfaces 2019 Aug 16;11(34):30518-30533. Epub 2019 Aug 16.

Chemical and Biomolecular Engineering Department , University of California-Los Angeles , Los Angeles , California 90095 , United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsami.9b07353DOI Listing
August 2019

DNA-Repair Gene Mutations Are Highly Prevalent in Circulating Tumour DNA from Multiple Myeloma Patients.

Cancers (Basel) 2019 Jun 29;11(7). Epub 2019 Jun 29.

Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne 3004, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11070917DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678219PMC
June 2019

Utility of Circulating Cell-Free RNA Analysis for the Characterization of Global Transcriptome Profiles of Multiple Myeloma Patients.

Cancers (Basel) 2019 Jun 25;11(6). Epub 2019 Jun 25.

Myeloma Research Group, Australian Centre for Blood Diseases (ACBD), Clinical Central School, Monash University, Melbourne 3004, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11060887DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628062PMC
June 2019

Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study).

Leuk Lymphoma 2019 09 11;60(9):2143-2151. Epub 2019 Jun 11.

Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital/Monash University , Melbourne , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1571201DOI Listing
September 2019

Role of Conventional Karyotyping in Multiple Myeloma in the Era of Modern Treatment and FISH Analysis.

Clin Lymphoma Myeloma Leuk 2019 08 28;19(8):e470-e477. Epub 2019 Apr 28.

National University Cancer Institute, National University Health System, Singapore, Singapore; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.04.011DOI Listing
August 2019

Psychometric properties of the Child Oral-care Performance Assessment Scale.

Community Dent Oral Epidemiol 2019 10 30;47(5):424-430. Epub 2019 May 30.

ARCPOH, Adelaide Dental School, University of Adelaide, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cdoe.12476DOI Listing
October 2019

Phase 2 study of all-oral ixazomib, cyclophosphamide and low-dose dexamethasone for relapsed/refractory multiple myeloma.

Br J Haematol 2019 02 20;184(4):536-546. Epub 2018 Nov 20.

Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15679DOI Listing
February 2019

-C-H arylation of fluoroarenes traceless directing group relay strategy.

Chem Sci 2018 Sep 25;9(35):7133-7137. Epub 2018 Jul 25.

School of Chemistry , University of Manchester , Oxford Road , Manchester , M13 9PL , UK . Email:

View Article

Download full-text PDF

Source
http://xlink.rsc.org/?DOI=C8SC02417K
Publisher Site
http://dx.doi.org/10.1039/c8sc02417kDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137440PMC
September 2018

Biomimetic cardiovascular platforms for in vitro disease modeling and therapeutic validation.

Biomaterials 2019 04 4;198:78-94. Epub 2018 Aug 4.

Department of Chemical and Biomolecular Engineering, University of California- Los Angeles, Los Angeles, CA 90095, USA; Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, Los Angeles, CA, USA; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01429612183056
Publisher Site
http://dx.doi.org/10.1016/j.biomaterials.2018.08.010DOI Listing
April 2019

Circulating Tumour DNA Analysis for Tumour Genome Characterisation and Monitoring Disease Burden in Extramedullary Multiple Myeloma.

Int J Mol Sci 2018 Jun 24;19(7). Epub 2018 Jun 24.

Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital⁻Monash University, Melbourne 3004, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms19071858DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073672PMC
June 2018

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.

J Clin Oncol 2018 08 31;36(23):2405-2412. Epub 2018 May 31.

Ajay K. Gopal, The University of Washington; Ajay K. Gopal, Fred Hutchinson Cancer Research Center, Seattle, WA; Stephen J. Schuster, Abramson Cancer Center of the University of Pennsylvania, Philadelphia; Jing-Zhou Hou, University of Pittsburgh Medical Center; Jing-Zhou Hou, University of Pittsburgh Cancer Institute, Pittsburgh; Rajendra N. Damle, Michael Schaffer, and Sriram Balasubramanian, Janssen Research & Development, Spring House, PA; Nathan H. Fowler, The University of Texas MD Anderson Cancer Center, Houston, TX; Judith Trotman, Concord Hospital, University of Sydney, Sydney, New South Wales; Andrew Spencer, Alfred Hospital-Monash University, Melbourne, Victoria; James Morton, Haematology and Oncology Clinics of Australia, Milton, Queensland, Australia; Georg Hess, Johannes Gutenberg-University, Mainz, Germany; Abdulraheem Yacoub, Kansas University Medical Center, Kansas City, KS; Michael Lill, Cedars-Sinai Medical Center, Los Angeles, CA; Peter Martin, Weill Cornell Medical College, Cornell University, New York, NY; Umberto Vitolo, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy; John Radford, University of Manchester; John Radford, Christie National Health Service Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; Wojciech Jurczak, Jagiellonian University, Kraków, Poland; Dolores Caballero, Hospital Clínico Universitario, Salamanca, Spain; Sanjay Deshpande, Gary J. Gartenberg, and Shean-Sheng Wang, Janssen Research & Development, Raritan, NJ; Jessica Vermeulen, Janssen Research & Development, Leiden, the Netherlands; Bruce D. Cheson, Georgetown University Hospital, Washington, DC; and Gilles Salles, Hospices Civils de Lyon-Université de Lyon, Pierre-Bénite cedex, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.8853DOI Listing
August 2018

Analysis of Circulating Tumor DNA.

Methods Mol Biol 2018 ;1792:129-145

Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-7865-6_9DOI Listing
February 2019

DCEP as a bridge to ongoing therapies for advanced relapsed and/or refractory multiple myeloma.

Leuk Lymphoma 2018 12 4;59(12):2842-2846. Epub 2018 Apr 4.

a Department of Clinical Haematology , Alfred Health , Melbourne , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1454595DOI Listing
December 2018

Critical review of the validity of patient satisfaction questionnaires pertaining to oral health care.

Community Dent Oral Epidemiol 2018 08 30;46(4):369-375. Epub 2018 Mar 30.

ARCPOH, Adelaide Dental School, University of Adelaide, Adelaide, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cdoe.12377DOI Listing
August 2018

Dental knowledge and dental service utilization: A 2-year follow-up study.

Community Dent Oral Epidemiol 2018 08 20;46(4):336-342. Epub 2018 Feb 20.

Australian Research Centre for Population Oral Health, Adelaide Dental School, The University of Adelaide, Adelaide, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cdoe.12371DOI Listing
August 2018

Extending Circulating Tumor DNA Analysis to Ultralow Abundance Mutations: Techniques and Challenges.

ACS Sens 2018 03 23;3(3):540-560. Epub 2018 Feb 23.

Myeloma Research Group, Australian Center for Blood Diseases , Monash University , Melbourne , Victoria 3004 , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acssensors.7b00953DOI Listing
March 2018

Circulating tumour DNA analysis in multiple myeloma.

Oncotarget 2017 Oct 7;8(53):90610-90611. Epub 2017 Oct 7.

Andrew Spencer: Australian Centre for Blood Diseases, Monash University, Malignant Haematology & Stem Cell Transplantation, Alfred Hospital and Department of Clinical Haematology, Monash University, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.21595DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710860PMC
October 2017

Factors Influencing Early Feeding of Foods and Drinks Containing Free Sugars-A Birth Cohort Study.

Int J Environ Res Public Health 2017 10 23;14(10). Epub 2017 Oct 23.

School of Public Health, Curtin University, Perth, WA 6845, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijerph14101270DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664771PMC
October 2017

Defibrotide for the treatment of sinusoidal obstruction syndrome: evaluation of response to therapy and patient outcomes.

Support Care Cancer 2018 Mar 11;26(3):947-955. Epub 2017 Oct 11.

Department of Malignant Haematology and Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-017-3915-1DOI Listing
March 2018

Cytomegalovirus Reactivation Is Associated with Increased Risk of Late-Onset Invasive Fungal Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Study in the Current Era of Viral Load Monitoring.

Biol Blood Marrow Transplant 2017 Nov 7;23(11):1961-1967. Epub 2017 Aug 7.

The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.07.025DOI Listing
November 2017

β-Catenin Inhibitor BC2059 Is Efficacious as Monotherapy or in Combination with Proteasome Inhibitor Bortezomib in Multiple Myeloma.

Mol Cancer Ther 2017 09 12;16(9):1765-1778. Epub 2017 May 12.

Myeloma Research Group, Australian Centre for Blood Diseases, Monash University/Alfred Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-16-0624DOI Listing
September 2017

An Evidence-Based Approach to Myeloma Bone Disease.

Curr Hematol Malig Rep 2017 04;12(2):109-118

Department of Haematology, Alfred Health, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11899-017-0370-5
Publisher Site
http://dx.doi.org/10.1007/s11899-017-0370-5DOI Listing
April 2017

Myeloma in the Real World: What Is Really Happening?

Clin Lymphoma Myeloma Leuk 2017 03 26;17(3):133-144.e1. Epub 2016 Dec 26.

Alfred Health, Melbourne, Victoria, Australia; Central Clinical School, Monash University, The Alfred Centre, Melbourne, Victoria, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.12.002DOI Listing
March 2017

Defibrotide for the management of sinusoidal obstruction syndrome in patients who undergo haemopoietic stem cell transplantation.

Cancer Treat Rev 2016 Nov 30;50:200-204. Epub 2016 Sep 30.

Department of Malignant Haematology and Stem Cell Transplantation, The Alfred Hospital, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2016.09.014DOI Listing
November 2016

Epigenetic regulation of miRNA-124 and multiple downstream targets is associated with treatment response in myeloid malignancies.

Oncol Lett 2016 Sep 25;12(3):2175-2180. Epub 2016 Jul 25.

Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria 3004, Australia; Translational Research Division, Eastern Clinical Research Unit, Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria 3004, Australia; Department of Medicine, Eastern Health Clinical School, Monash University, Melbourne, Victoria 3128, Australia.

View Article

Download full-text PDF

Source
https://www.spandidos-publications.com/10.3892/ol.2016.4912
Publisher Site
http://dx.doi.org/10.3892/ol.2016.4912DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998575PMC
September 2016

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.

N Engl J Med 2016 Aug;375(8):754-66

From the Department of Hematology, University of Turin, Turin, Italy (A.P.); the Division of Hematology and Medical Oncology, Mayo Clinic Florida, Jacksonville (A.C.-K.); Universitaetsklinikum Tuebingen der Eberhard-Karls-Universitaet, Abteilung fuer Innere Medizin II, Tuebingen (K.W.), and University Medical Center of the Johannes Gutenberg-University, Third Department of Medicine, Mainz (M.M.) - both in Germany; Winship Cancer Institute, Emory University, Atlanta (A.K.N.); the Department of Hematology and Stem Cell Transplantation, St. László Hospital, Semmelweis University, Budapest, Hungary (T.M.); Ankara University, Department of Hematology, Ankara, Turkey (M.B.); Clinical Department of Hematology, 1st Medical Department, Charles University in Prague, Prague, Czech Republic (I.S.); Irmandade Da Santa Casa De Misericordia De São Paulo, São Paulo (V.H.); University Hospital of Salamanca-Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain (M.V.M.); Weill Cornell Medical College, New York (T.M.M.); Janssen Research and Development, Spring House, PA (M.Q., X.Q., T.A.); Janssen Research and Development, Raritan, NJ (J.S., H.A.); Janssen Research and Development, Beerse, Belgium (W.D.); Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, VIC, Australia (A.S.); and the Department of Hematology, Erasmus MC, Rotterdam, the Netherlands (P.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1606038DOI Listing
August 2016

Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies.

Cancer Biol Med 2016 Jun;13(2):215-25

Myeloma Research Group, Australian Center for Blood Diseases, Monash University, Melbourne 3004, Australia; Malignant Haematology & Stem Cell Transplantation Service, Alfred Hospital, Melbourne 3004, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.20892/j.issn.2095-3941.2016.0025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944540PMC
June 2016

Myeloma of the central nervous system - an ongoing conundrum!

Leuk Lymphoma 2016 07 21;57(7):1505-6. Epub 2016 Mar 21.

c St Vincent's Hospital , Melbourne , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2016.1154961DOI Listing
July 2016

Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.

J Antimicrob Chemother 2016 Feb 30;71(2):497-505. Epub 2015 Oct 30.

Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia

View Article

Download full-text PDF

Source
http://jac.oxfordjournals.org/content/early/2015/10/29/jac.d
Web Search
http://www.jac.oxfordjournals.org/lookup/doi/10.1093/jac/dkv
Publisher Site
http://dx.doi.org/10.1093/jac/dkv343DOI Listing
February 2016

Comment on "Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma".

Haematologica 2015 Sep;100(9):e379

Peter MacCallum Cancer Centre, East Melbourne, Australia Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.128470DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800680PMC
September 2015

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.

J Clin Oncol 2015 Sep 3;33(26):2863-9. Epub 2015 Aug 3.

Antonio Palumbo, Stefania Oliva, Simona Caltagirone, Sara Bringhen, and Francesca Gay, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute della Salute e della Scienza di Torino; Roberto Passera, University of Torino, Torino; Massimo Offidani, Clinica di Ematologia, AUO Ospedali Riuniti di Ancona, Ancona; Pellegrino Musto, Istituto di Ricovero e Cura a Carattere Scientifico, Referral Cancer Center of Basilicata, Rionero in Vulture; Maria T. Petrucci, Sapienza University of Rome, Rome; Elena Zamagni and Michele Cavo, Istituto di Ematologia Seragnoli, Università di Bologna, Bologna, Italy; Hervé Avet-Loiseau and Michel Attal, Institut Claudius Regaud, L'Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse; Thierry Facon, Service des Maladies du Sang, Hôpital Claude Huriez, Centre Hospitalier Regionale et Universitaire Lille, Lille; Philippe Moreau, University Hospital Hotel-Dieu, Nantes, France; Henk M. Lokhorst, VU University Medical Center, Amsterdam; Pieter Sonneveld, Erasmus MC, Rotterdam, the Netherlands; Hartmut Goldschmidt, University Hospital and National Center for Tumor Diseases Heidelberg, Heidelberg, Germany; Laura Rosinol, Hospital Clínic, Institut Clínic d'Investigacions Biomèdiques Ausgust Pi i Sunyer, Barcelona; Juan José Lahuerta, Hospital Universitario 12 de Octubre, Madrid; Jésus San Miguel, Clínica Universidad de Navarra, Centro de Investigaciones Médicas Aplicadas, IDISNA, Pamplona, Spain; Paul Richardson and Kenneth C. Anderson, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA; Shaji Kumar and S. Vincent Rajkumar, Mayo Clinic, Rochester, MN; Sagar Lonial, Winship Cancer Institute, Emory University, Atlanta, GA; Robert Z. Orlowski, The University of Texas MD Anderson Comprehensive Cancer Center, Houston, TX; Gareth Morgan, Myeloma Institutes for Research Therapy, University of Arkansas for Medical Sciences, Little Rock, AR; Brian G.M. Durie, Cedars-Sinai Comprehensive Canc

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/08/03/JCO.2015.61
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.61.2267
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.61.2267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846284PMC
September 2015

Pharmacologic inhibition of intestinal sodium uptake: a gut centric approach to sodium management.

Curr Opin Nephrol Hypertens 2015 Sep;24(5):410-6

aArdelyx, Inc., Fremont, California, USA bAstraZeneca Research and Development, Mölndal, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNH.0000000000000154DOI Listing
September 2015

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma.

N Engl J Med 2015 Aug 2;373(7):621-31. Epub 2015 Jun 2.

From Winship Cancer Institute, Emory University School of Medicine, Atlanta (S.L.); National and Kapodistrian University of Athens, Athens (M.D.); A.O.U. San Giovanni Battista di Torino-Ospedale Molinette, Turin, Italy (A.P.); QEII Health Science Center and Dalhousie University, Halifax, NS (D.W.), Cross Cancer Institute and University of Alberta, Edmonton (A.B.), and Princess Margaret Cancer Centre, Toronto (D.R.) - all in Canada; Silesian Medical University, Katowice (S.G.), and Medical University of Lublin, Lublin (A.W.-C.) - both in Poland; Charles University Hospital, Prague, Czech Republic (I.S.); University Hospital, Nantes, France (P.M.); Complejo Asistencial Universitario de Salamanca-Instituto de Investigación Biomédica de Salamanca, Salamanca (M.-V.M.), and Clinica Universidad de Navarra-Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Pamplona (J.S.-M.) - both in Spain; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Ramat Aviv - both in Israel (H.M.); Ankara University, Ankara, Turkey (M.B.); Alfred Health-Monash University, Melbourne, VIC, Australia (A. Spencer); Barts and the London NHS Trust, London (H.O.); University of Texas M.D. Anderson Cancer Center, Houston (R.Z.O.); Kyoto Prefectural University of Medicine, Kyoto (M.T.), and Nishigunma National Hospital, Shibukawa (M.M.) - both in Japan; Universitätsklinikum der Technische Universität, Dresden (C.R.), and Universitätsklinikum Würzburg, Würzburg (H.E.) - both in Germany; Zeikenhuis Netwerk Antwerpen (ZNA) Stuivenberg, Antwerp, Belgium (K.L.W.); AbbVie Biotherapeutics, Redwood City, CA (A. Singhal); Bristol-Myers Squibb, Princeton, NJ (J.K.), Wallingford, CT (E.B.), and Braine-l'Alleud, Belgium (V.P.); and Dana-Farber Cancer Institute, Boston (K.C.A., P.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1505654DOI Listing
August 2015

The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefit.

Am J Hematol 2015 May 27;90(5):E86-91. Epub 2015 Feb 27.

Peter MacCallum Cancer Centre, East Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23967DOI Listing
May 2015

Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia.

Br J Haematol 2015 Apr 2;169(2):199-210. Epub 2015 Feb 2.

Department of Clinical Haematology, The Alfred Hospital, Melbourne, Vic., Australia; The Australian Centre for Blood Diseases, Monash University, Melbourne, Vic., Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13281DOI Listing
April 2015

Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma.

Epigenetics 2014 Nov;9(11):1511-20

a Myeloma Research Group; Division of Blood Cancers; Australian Center for Blood Diseases; Alfred Hospital; Monash University ; Melbourne , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/15592294.2014.983367DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622977PMC
November 2014

A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia.

Haematologica 2015 Feb 7;100(2):e60-2. Epub 2014 Nov 7.

Alfred Hospital, Myeloma Research Group, Australian Centre for Blood Diseases, Monash University, Melbourne

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.111385DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803129PMC
February 2015

Comparison of the probability of target attainment of anidulafungin against Candida spp. in patients with acute leukaemia.

Int J Antimicrob Agents 2014 Nov 6;44(5):450-7. Epub 2014 Sep 6.

Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijantimicag.2014.07.019DOI Listing
November 2014